The Contract Research Associate will be responsible for assisting in the development and optimization of the production and purification of AAV therapies in Lexeo's NYC lab. The successful candidate will master the downstream purification process and become a driver of process innovation. The Contract Research Associate will have the opportunity to learn at a fast-paced startup company with multiple ongoing clinical trials for novel cardiac and neurodegenerative gene therapies. The Research Associate’s work will directly impact ongoing and future clinical trials.
LEXEO Therapeutics is a New York City-based, clinical-stage gene therapy company focused on addressing some of the most devastating genetically defined cardiovascular and central nervous system diseases affecting both larger-rare and prevalent patient populations. LEXEO’s foundational science stems from partnerships and exclusive licenses with leading academic laboratories at Weill Cornell Medicine and the University of California, San Diego. LEXEO is advancing a deep and diverse pipeline of AAV-based gene therapy candidates in rare cardiovascular diseases and APOE4-associated Alzheimer’s disease and is led by pioneers and experts with decades of collective experience in genetic medicines, rare disease drug development, manufacturing, and commercialization.
Lexeo Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.